Henry Schein (HSIC) fundamentals: P/E, valuation, undervalued?
Henry Schein · Health Care · ref. ETF XLV · price $85.03
In short — Henry Schein trades at 24.6× earnings (P/E), 14.2× forward, with a net margin of 3.0 % and revenue growth of +7 %. Read: Cheap for the growth (P/E 14 for ~17% growth (PEG 0.8)).
Is Henry Schein stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$85.03+34.1% over range
Oct 14, 25low $62.03 · high $90.86Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
50% recommend buying · 8 analysts
Valuation : Cheap for the growth — P/E 14 for ~17% growth (PEG 0.8)
Valuation
24.6
P/E (price/earnings)
14.2
Forward P/E
1.44
PEG
3.0
Price/book (P/B)
$9.7B
Market cap
3.46
EPS
Profitability & growth
3.0 %
Net margin
+7 %
Revenue growth
+17 %
Earnings growth
$3.8B
Total debt
Henry Schein income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $12.6B | $538M | 4.3 % |
| 2023 | $12.3B | $416M | 3.4 % |
| 2024 | $12.7B | $390M | 3.1 % |
| 2025 | $13.2B | $398M | 3.0 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Henry Schein's P/E and is the stock undervalued? What's a good P/E?
Henry Schein's P/E is 24.6 (forward 14.2). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Henry Schein profitable?
Henry Schein has a net margin of 3.0 % (EPS 3.46). The company is profitable.
Is HSIC stock expensive?
Our read: "Cheap for the growth" — P/E 14 for ~17% growth (PEG 0.8). Cross-check with growth and sector.
💬 A question about Henry Schein? The JPI assistant answers using our backtest data.
Keep exploring Henry Schein